These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
374 related articles for article (PubMed ID: 23365085)
21. Multi-task learning sparse group lasso: a method for quantifying antigenicity of influenza A(H1N1) virus using mutations and variations in glycosylation of Hemagglutinin. Li L; Chang D; Han L; Zhang X; Zaia J; Wan XF BMC Bioinformatics; 2020 May; 21(1):182. PubMed ID: 32393178 [TBL] [Abstract][Full Text] [Related]
23. Reverse engineering the antigenic architecture of the haemagglutinin from influenza H5N1 clade 1 and 2.2 viruses with fine epitope mapping using monoclonal antibodies. Rockman S; Camuglia S; Vandenberg K; Ong C; Baker MA; Nation RL; Li J; Velkov T Mol Immunol; 2013 Apr; 53(4):435-42. PubMed ID: 23127859 [TBL] [Abstract][Full Text] [Related]
24. Predicting the antigenic structure of the pandemic (H1N1) 2009 influenza virus hemagglutinin. Igarashi M; Ito K; Yoshida R; Tomabechi D; Kida H; Takada A PLoS One; 2010 Jan; 5(1):e8553. PubMed ID: 20049332 [TBL] [Abstract][Full Text] [Related]
25. Genetic Characterization of Influenza A (H1N1) Pandemic 2009 Virus Isolates from Mumbai. Gohil D; Kothari S; Shinde P; Meharunkar R; Warke R; Chowdhary A; Deshmukh R Curr Microbiol; 2017 Aug; 74(8):899-907. PubMed ID: 28497210 [TBL] [Abstract][Full Text] [Related]
26. A mutation in the receptor binding site enhances infectivity of 2009 H1N1 influenza hemagglutinin pseudotypes without changing antigenicity. Wang W; Castelán-Vega JA; Jiménez-Alberto A; Vassell R; Ye Z; Weiss CD Virology; 2010 Nov; 407(2):374-80. PubMed ID: 20869738 [TBL] [Abstract][Full Text] [Related]
27. Development of neutralizing monoclonal antibodies against the pandemic H1N1 virus (2009) using plasmid DNA immunogen. Cabral TM; Baig A; Berhane Y; Schmidt L; Hole K; Leith M; Kobasa D; Corbett CR J Virol Methods; 2014 Jan; 195():54-62. PubMed ID: 24060631 [TBL] [Abstract][Full Text] [Related]
29. Mutations in Influenza A Virus Neuraminidase and Hemagglutinin Confer Resistance against a Broadly Neutralizing Hemagglutinin Stem Antibody. Prachanronarong KL; Canale AS; Liu P; Somasundaran M; Hou S; Poh YP; Han T; Zhu Q; Renzette N; Zeldovich KB; Kowalik TF; Kurt-Yilmaz N; Jensen JD; Bolon DNA; Marasco WA; Finberg RW; Schiffer CA; Wang JP J Virol; 2019 Jan; 93(2):. PubMed ID: 30381484 [TBL] [Abstract][Full Text] [Related]
30. N-Linked Glycan Sites on the Influenza A Virus Neuraminidase Head Domain Are Required for Efficient Viral Incorporation and Replication. Östbye H; Gao J; Martinez MR; Wang H; de Gier JW; Daniels R J Virol; 2020 Sep; 94(19):. PubMed ID: 32699088 [TBL] [Abstract][Full Text] [Related]
31. Immunization with a low dose of hemagglutinin-encoding plasmid protects against 2009 H1N1 pandemic influenza virus in mice. Fang J; Chen Z; Liu X; Li H; Wang J; Shen X; Chen W; Liu Y; Wang Y; Zhao P; Qi Z J Virol Methods; 2011 May; 173(2):314-9. PubMed ID: 21392537 [TBL] [Abstract][Full Text] [Related]
32. Genetic requirement for hemagglutinin glycosylation and its implications for influenza A H1N1 virus evolution. Kim JI; Lee I; Park S; Hwang MW; Bae JY; Lee S; Heo J; Park MS; García-Sastre A; Park MS J Virol; 2013 Jul; 87(13):7539-49. PubMed ID: 23637398 [TBL] [Abstract][Full Text] [Related]
33. Predicted Enhanced Human Propensity of Current Avian-Like H1N1 Swine Influenza Virus from China. Veljkovic V; Veljkovic N; Paessler S; Goeijenbier M; Perovic V; Glisic S; Muller CP PLoS One; 2016; 11(11):e0165451. PubMed ID: 27828989 [TBL] [Abstract][Full Text] [Related]
34. Molecular characterization and phylogenetic analysis of the hemagglutinin 1 protein of human influenza A virus subtype H1N1 circulating in Kenya during 2007-2008. Bulimo WD; Achilla RA; Majanja J; Mukunzi S; Wadegu M; Osunna F; Mwangi J; Njiri J; Wangui J; Nyambura J; Obura B; Mitei K; Omariba D; Segecha S; Nderitu M; Odindo A; Adega C; Kiponda J; Mupa R; Munyazi F; Kissinger G; Mwakuzimu M; Kamola D; Muhidin E; Kamau D; Kairithia S; Koech M; Sang A; Onge'ta L; Schnabel DC J Infect Dis; 2012 Dec; 206 Suppl 1():S46-52. PubMed ID: 23169971 [TBL] [Abstract][Full Text] [Related]
35. Molecular evolution of HA gene of the influenza A H1N1 pdm09 strain during the consecutive seasons 2009-2011 in Hangzhou, China: several immune-escape variants without positively selected sites. Li J; Shao TJ; Yu XF; Pan JC; Pu XY; Wang HQ; Kou Y J Clin Virol; 2012 Dec; 55(4):363-6. PubMed ID: 22921413 [TBL] [Abstract][Full Text] [Related]
36. Site-specific glycosylation profile of influenza A (H1N1) hemagglutinin through tandem mass spectrometry. Cruz E; Cain J; Crossett B; Kayser V Hum Vaccin Immunother; 2018 Mar; 14(3):508-517. PubMed ID: 29048990 [TBL] [Abstract][Full Text] [Related]
37. Playing hide and seek: how glycosylation of the influenza virus hemagglutinin can modulate the immune response to infection. Tate MD; Job ER; Deng YM; Gunalan V; Maurer-Stroh S; Reading PC Viruses; 2014 Mar; 6(3):1294-316. PubMed ID: 24638204 [TBL] [Abstract][Full Text] [Related]
38. Characterization of an enhanced antigenic change in the pandemic 2009 H1N1 influenza virus haemagglutinin. García-Barreno B; Delgado T; Benito S; Casas I; Pozo F; Cuevas MT; Mas V; Trento A; Rodriguez-Frandsen A; Falcón A; Ortín J; Nieto A; Melero JA J Gen Virol; 2014 May; 95(Pt 5):1033-1042. PubMed ID: 24531414 [TBL] [Abstract][Full Text] [Related]
39. Comparison of selection pressures on the HA gene of pandemic (2009) and seasonal human and swine influenza A H1 subtype viruses. Furuse Y; Shimabukuro K; Odagiri T; Sawayama R; Okada T; Khandaker I; Suzuki A; Oshitani H Virology; 2010 Sep; 405(2):314-21. PubMed ID: 20598336 [TBL] [Abstract][Full Text] [Related]